Flora Growth Inc (NASDAQ:FLGC) downgraded by Zacks Investment Research to Hold


Zacks Investment Research cut pieces of Flora growth (NASDAQ: FLGCGet a rating) from a buy rating to a hold rating in a research report sent to investors on Monday morning, Zacks.com reports.

According to Zacks, “Flora Growth Corp. is a cultivator and manufacturer of cannabis-derived products and brands. Flora Growth Corp. is based in TORONTO. “

Shares of NASDAQ FLGC opened at $1.25 on Monday. The company has a 50-day moving average price of $1.69 and a 200-day moving average price of $2.07. The company has a debt ratio of 0.01, a current ratio of 7.84 and a quick ratio of 7.34. Flora Growth has a 52-week low of $1.10 and a 52-week high of $21.45.

Several hedge funds have recently bought and sold shares of FLGC. Flow Traders US LLC bought a new position in shares of Flora Growth during the first quarter for a value of approximately $26,000. Morgan Stanley acquired a new stake in Flora Growth during Q2 worth $27,000. Financial Consulate Inc. acquired a new stake in Flora Growth during the 4th quarter at a value of $29,000. Wedbush Securities Inc. bought a new position in Flora Growth during Q4 worth $45,000. Finally, Citadel Advisors LLC increased its stake in Flora Growth by 178.5% in the fourth quarter. Citadel Advisors LLC now owns 30,307 shares of the company valued at $54,000 after purchasing an additional 19,425 shares during the period. 8.08% of the shares are held by institutional investors and hedge funds.

Flora Growth Company Profile (Get a rating)

Flora Growth Corp., a cannabis company, cultivates, processes and supplies cannabis-based products to pharmacies, medical clinics and cosmetic companies around the world. It cultivates, processes and supplies medical grade cannabis oil, cannabis oil extracts and related products; manufactures and sells skin care and beauty products, such as cleansing gels, eye creams, moisturizers and moisturizing masks; manufactures dermo-cosmetic products; and develops and sells pharmaceutical and over-the-counter products, including dietary supplements, herbal and nutraceutical products, supplements and related products.

Recommended Stories

Get a Free Copy of Zacks’ Flora Growth (FLGC) Research Report

For more information on Zacks Investment Research’s research offerings, visit Zacks.com

Get news and reviews for Flora Growth Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings for Flora Growth and related companies with MarketBeat.com’s FREE daily newsletter.


Comments are closed.